Walsh & Associates »

ResMed shares owned by Walsh & Associates

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Walsh & Associates from 13F filings

Historical chart of Walsh & Associates investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Walsh & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Walsh & Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $27k 120 224.48
2025-12-31 $29k 120 240.87

More positions owned by Walsh & Associates

Ishares Russell MF Closed and MF Open (IWF)
State Street MF Closed and MF Open (SPYG)
State Street MF Closed and MF Open (SPYV)
Dimensional Us MF Closed and MF Open (DFUV)
State Street MF Closed and MF Open (SPEM)
State Street MF Closed and MF Open (SPDW)
Dimensional Us MF Closed and MF Open (DFAT)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
State Street MF Closed and MF Open (MDYG)
Adams Diversified MF Closed and MF Open (ADX)
Ishares Core MF Closed and MF Open (ITOT)
State Street MF Closed and MF Open (SPTM)
State Street MF Closed and MF Open (SLYG)
Ishares Russ MF Closed and MF Open (IWS)

View all positions for Walsh & Associates

Top funds holding ResMed

Vanguard Group
BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Morgan Stanley
Invesco
Northern Trust
First Trust Advisors
Deutsche Bank Aktiengesellschaft
Swedbank AB
Charles Schwab Investment Management
Amundi

View all funds holding ResMed